Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  CDA inhibitor E7727/decitabine combination agent ASTX727
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ASTX727-01, NCI-2014-01304, NCT02103478
Start Over